Tuesday, January 15, 2008 7:09:31 AM
Tuesday January 15, 5:30 am ET
CHASKA, Minn.--(BUSINESS WIRE)--LIFECORE BIOMEDICAL, INC. (NASDAQ:LCBM - News) announced today that it has entered into a definitive agreement with affiliates of Warburg Pincus, the global private equity firm, to be acquired through a tender offer, followed by a merger, for a price of $17.00 per share in cash. The transaction, valued at approximately $239 million, is subject to the valid tender of a majority of Lifecore Biomedical’s fully diluted common shares, regulatory approvals and other customary conditions, but is not subject to any financing condition.
http://biz.yahoo.com/bw/080115/20080115005561.html?.v=1
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM